BANK OF MONTREAL /CAN/ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19,296,234
+171.5%
431,973
+454.3%
0.01%
+250.0%
Q2 2023$7,107,630
+36.1%
77,926
-22.8%
0.00%0.0%
Q4 2022$5,224,189
-41.5%
100,931
-22.0%
0.00%
-50.0%
Q3 2022$8,924,000
+14.3%
129,339
-23.1%
0.00%0.0%
Q2 2022$7,809,000
-6.2%
168,125
+0.0%
0.00%0.0%
Q1 2022$8,325,000
-5.1%
168,107
-6.4%
0.00%
-20.0%
Q4 2021$8,768,000
+1.7%
179,681
-29.2%
0.01%
+25.0%
Q3 2021$8,618,000
-47.1%
253,728
-0.3%
0.00%
-50.0%
Q2 2021$16,293,000
+106.2%
254,493
+33.8%
0.01%
+60.0%
Q1 2021$7,901,000
-11.9%
190,145
+19.3%
0.01%
-16.7%
Q4 2020$8,967,000
-19.7%
159,339
-53.6%
0.01%
-33.3%
Q3 2020$11,172,000
+5.1%
343,320
+2.5%
0.01%
-10.0%
Q2 2020$10,627,000
+502.4%
334,830
+396.0%
0.01%
+400.0%
Q1 2020$1,764,000
-55.8%
67,500
-48.2%
0.00%
-33.3%
Q4 2019$3,989,000
+3810.8%
130,268
+2972.4%
0.00%
Q3 2019$102,000
-1.0%
4,240
+4.7%
0.00%
Q2 2019$103,000
+1371.4%
4,048
+696.9%
0.00%
Q4 2018$7,000
+75.0%
508
+104.0%
0.00%
Q3 2018$4,000
-33.3%
249
-2.7%
0.00%
Q2 2018$6,0002560.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders